Article Details
Retrieved on: 2024-05-21 15:22:16
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
AstraZeneca: Analysts at Jefferies said the revenue target of $80 billion was widely expected, adding that major new drug catalysts are "somewhat ...
Article found on: health.economictimes.indiatimes.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here